Name: | Akebia Therapeutics, Inc. |
Jurisdiction: | MISSISSIPPI |
Business Type: | Profit Corporation |
Status: | Good Standing |
Effective Date: | 25 Feb 2019 (6 years ago) |
Business ID: | 1169959 |
State of Incorporation: | DELAWARE |
Principal Office Address: | 245 First Street, c/o Akebia Therapeutics, Inc.Cambridge, MA 02142 |
Name | Role | Address |
---|---|---|
C. T. CORPORATION SYSTEM | Agent | 645 LAKELAND EAST DRIVE STE 101, FLOWOOD, MS 39232 |
Name | Role | Address |
---|---|---|
John P. Butler | President | 245 FIRST ST, CAMBRIDGE, MA 02142 |
Name | Role | Address |
---|---|---|
Nicole R. Hadas | Secretary | 245 FIRST ST, c/o Akebia Therapeutics, Inc., Cambridge, MA 02142 |
Name | Role | Address |
---|---|---|
John P. Butler | Director | 245 FIRST ST, CAMBRIDGE, MA 02142 |
Michael Rogers | Director | 245 FIRST ST, CAMBRIDGE, MA 02142 |
Adrian Adams | Director | 245 FIRST ST, CAMBRIDGE, MA 02142 |
Myles Wolf, M.D., M.M.SC. | Director | 245 FIRST ST, CAMBRIDGE, MA 02142 |
Steven C. Gilman. PH.D. | Director | 245 FIRST ST, CAMBRIDGE, MA 02142 |
Cynthia Smith | Director | 245 FIRST ST, CAMBRIDGE, MA 02142 |
Ron Frieson | Director | 245 FIRST STREET, 14TH FLOOR, CAMBRIDGE, MA 02142 |
LeAnne Zumwalt | Director | 245 First Street, 14th Floor, Cambridge, MA 02142 |
Type | Status | Filed Date | Description |
---|---|---|---|
Annual Report | Filed | 2024-03-20 | Annual Report For Akebia Therapeutics, Inc. |
Reinstatement | Filed | 2023-02-03 | Reinstatement For Akebia Therapeutics, Inc. |
Admin Dissolution | Filed | 2022-11-28 | Action of Intent to Dissolve: AR: Akebia Therapeutics, Inc. |
Notice to Dissolve/Revoke | Filed | 2022-09-05 | Notice of Intent to Dissolve: AR: Akebia Therapeutics, Inc. |
Annual Report | Filed | 2021-10-05 | Annual Report For Akebia Therapeutics, Inc. |
Notice to Dissolve/Revoke | Filed | 2021-09-07 | Notice of Intent to Dissolve: AR: Akebia Therapeutics, Inc. |
Annual Report | Filed | 2020-06-09 | Annual Report For Akebia Therapeutics, Inc. |
Formation Form | Filed | 2019-02-25 | Formation For Akebia Therapeutics, Inc. |
Date of last update: 16 Jan 2025
Sources: Mississippi Secretary of State